Journal of cardiovascular pharmacology
-
J. Cardiovasc. Pharmacol. · Dec 2008
Randomized Controlled TrialProtective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
To evaluate whether ambroxol administered orally during the perioperative period has a protective effect against postoperative pulmonary dysfunction in on-pump coronary artery bypass surgery. ⋯ In on-pump coronary artery bypass grafting, ambroxol improves postoperative PFTs and PaO2 levels without any significant clinical implication, and it exerts these effects possibly in ways other than surfactant modulation.